BCL10 Antikörper (AA 122-168)
-
- Target Alle BCL10 Antikörper anzeigen
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Bindungsspezifität
- AA 122-168
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL10 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)
- Spezifität
- Human BCL10 / BCL-10
- Aufreinigung
- Protein G purified
- Immunogen
-
Human Bcl10 recombinant protein (epitope aa122-168).
Type of Immunogen: Recombinant protein - Klon
- BL10-411
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product BCL10 Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, Flo (0.5 - 1 μg/10 x106), IF (1 - 2 μg/mL), IHC, IHC-P (0.5 - 1 μg/mL), IP, WB (0.5 - 1 μg/mL)
Usage: Bcl10, with an N-terminal caspase recruitment domain (CARD), is found in a number of apoptotic regulatory molecules. It was identified through its direct involvement in t(1.14) of mucosa-associated lymphoid tissue (MALT) lymphoma. Expression of Bcl10 was shown to induce NF?B activation in a NIK-dependent pathway. This antibody labels subpopulations of normal B and T cells and is a useful tool for the sub-classification of lymphomas. In MALT lymphomas with the t(1.14) translocation, while 55 % of MALT lymphomas lacking this translocation exhibited the same labeling pattern, although at a much lower level. ELISA: Order BSA-free antibody format for coating. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4, 0.1 mg/mL BSA, 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2°C to 8°C.
-
- Target
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
- Andere Bezeichnung
- BCL10 / BCL-10 (BCL10 Produkte)
- Synonyme
- CARMEN antikoerper, CIPER antikoerper, CLAP antikoerper, c-E10 antikoerper, mE10 antikoerper, BCL10 antikoerper, AI132454 antikoerper, BCL-10 antikoerper, C81403 antikoerper, ME10 antikoerper, cE10 antikoerper, bcl10 antikoerper, B-cell CLL/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10-like antikoerper, B cell leukemia/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10 antikoerper, BCL10 antikoerper, Bcl10 antikoerper, bcl10 antikoerper, LOC100223183 antikoerper
- Hintergrund
-
Name/Gene ID: BCL10
Family: Apoptosis
Synonyms: BCL10, Bcl-10, B-cell CLL/lymphoma 10, B-cell lymphoma/leukemia 10, CARMEN, CARD-like apoptotic protein, CCARMEN, C-E10, CIPER, Cellular-E10, HCLAP, Cellular homolog of vCARMEN, CLAP, ME10 - Gen-ID
- 8915
- Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
-